» Articles » PMID: 37679653

A Novel Risk Model for Predicting Peritoneal Metastasis in Colorectal Cancer Based on the SEER Database

Overview
Specialty Oncology
Date 2023 Sep 7
PMID 37679653
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early detection and intervention could significantly improve the prognosis of patients with peritoneal metastasis (PM). Our main purpose was to develop a model to predict the risk of PM in patients with colorectal cancer (CRC).

Methods: Patients from the Surveillance, Epidemiology, and End Results (SEER) database with CRC classified according to the AJCC 8th TNM staging system were selected for the study. After data pre-processing, the dataset was divided into a training set and a validation set. In the training set, univariate logistic analysis and stepwise multivariate logistic regression analysis were utilized to screen clinical features and construct a risk prediction model. Then, we validated the model using the confusion matrix, receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration curves to examine its performance.

Results: The model constructed using stepwise multivariate logistic regression analysis incorporated the following eight clinical features: age, tumor location, histological type, T stage, carcinoembryonic antigen (CEA) level, tumor deposits (TDs), log odds (LODDS) of metastatic lymph nodes, and extraperitoneal metastasis (EM). The areas under the curve (AUCs) of the model in the training and validation sets were 0.924 and 0.912, respectively. The accuracy and the recall ratio were higher than 0.8 in both cohorts. DCA and the calibration curves also confirmed its excellent predictive power.

Conclusions: Our model can effectively predict the risk of PM in CRC patients, which is of great significance for the timely identification of patients at high risk of PM and further clinical decision-making.

Citing Articles

Multimodal deep learning: tumor and visceral fat impact on colorectal cancer occult peritoneal metastasis.

Miao S, Sun M, Zhang B, Jiang Y, Xuan Q, Wang G Eur Radiol. 2025; .

PMID: 39961863 DOI: 10.1007/s00330-025-11450-2.


Prognostic prediction and comparison of three staging programs for patients with advanced (T2-T4) esophageal squamous carcinoma after radical resection.

Wang Z, Li F, Zhu M, Lu T, Wen L, Yang S Front Oncol. 2024; 14:1376527.

PMID: 38993638 PMC: 11236680. DOI: 10.3389/fonc.2024.1376527.


A radiomics-boosted deep-learning for risk assessment of synchronous peritoneal metastasis in colorectal cancer.

Zhang D, Zheng B, Xu L, Wu Y, Shen C, Bao S Insights Imaging. 2024; 15(1):150.

PMID: 38886244 PMC: 11183032. DOI: 10.1186/s13244-024-01733-5.

References
1.
Abdel-Rahman O . A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery. Int J Colorectal Dis. 2020; 35(4):719-725. DOI: 10.1007/s00384-020-03525-x. View

2.
Ban B, Shang A, Shi J . Development and validation of a nomogram for predicting metachronous peritoneal metastasis in colorectal cancer: A retrospective study. World J Gastrointest Oncol. 2023; 15(1):112-127. PMC: 9850763. DOI: 10.4251/wjgo.v15.i1.112. View

3.
Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H . Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2009; 53(1):57-64. DOI: 10.1007/DCR.0b013e3181c703a4. View

4.
Biller L, Schrag D . Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021; 325(7):669-685. DOI: 10.1001/jama.2021.0106. View

5.
Du S, Miao J, Zhu Z, Xu E, Shi L, Ai S . NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR. Cell Death Dis. 2018; 9(10):948. PMC: 6148243. DOI: 10.1038/s41419-018-0953-7. View